# Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel

> **NCT05253755** · PHASE2 · TERMINATED · sponsor: **DermBiont, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **BIOLOGICAL:** DBI-001
- **BIOLOGICAL:** Aqueous gel

## Key facts

- **NCT ID:** NCT05253755
- **Lead sponsor:** DermBiont, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-10-06
- **Primary completion:** 2022-09-09
- **Final completion:** 2022-09-09
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Sponsor suspension and not due to safety or site-related matters.
- **Last updated:** 2023-11-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05253755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05253755, "Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05253755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*